Clinical responses observed with imatinib or sorafenib in melanoma patients expressing mutations in KIT
D Handolias, AL Hamilton, R Salemi, A Tan, K Moodie, L Kerr, A Dobrovic, GA McArthur
British Journal of Cancer | NATURE PUBLISHING GROUP | Published : 2010
We thank Novartis for their financial support, Victoria Beshay for mutation screening, Boris Bastian, Glenn Lynch and Petranel Ferrao for discussion and Jill Magee, Chris Angel and Graham Mason for their pathology input. Thanks to Kathryn Kinross for assistance with images. This work was supported by grants from the NHMRC and a Sir Edward Dunlop Clinical Research Fellowship from the Cancer Council of Victoria (GA McArthur) and an Australian Postgraduate Award from the University of Melbourne (D Handolias).